Back to User profile » Dr Jing Yu

Papers published by Dr Jing Yu:


Topical Application of Cell-Penetrating Peptide Modified Anti-VEGF Drug Alleviated Choroidal Neovascularization in Mice

Hu W, Cai W, Wu Y, Ren C, Yu D, Li T, Shen T, Xu D, Yu J

International Journal of Nanomedicine 2024, 19:35-51

Published Date: 3 January 2024

Grape Seed Proanthocyanidin Extract Moderated Retinal Pigment Epithelium Cellular Senescence Through NAMPT/SIRT1/NLRP3 Pathway

Wan W, Zhu W, Wu Y, Long Y, Liu H, Wan W, Wan G, Yu J

Journal of Inflammation Research 2021, 14:3129-3143

Published Date: 12 July 2021

Quercetin inhibits transforming growth factor β1-induced epithelial–mesenchymal transition in human retinal pigment epithelial cells via the Smad pathway

Cai W, Yu D, Fan J, Liang X, Jin H, Liu C, Zhu M, Shen T, Zhang R, Hu W, Wei Q, Yu J

Drug Design, Development and Therapy 2018, 12:4149-4161

Published Date: 6 December 2018

17β-estradiol ameliorates oxidative stress and blue light-emitting diode-induced retinal degeneration by decreasing apoptosis and enhancing autophagy

Wei Q, Liang X, Peng Y, Yu D, Zhang R, Jin H, Fan J, Cai W, Ren C, Yu J

Drug Design, Development and Therapy 2018, 12:2715-2730

Published Date: 4 September 2018

Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema [Corrigendum]

Liu QY, He MM, Shi H, Wang QY, Du YR, Liu JL, Ren CD, Xu D, Yu J

Drug Design, Development and Therapy 2016, 10:1547-1548

Published Date: 27 April 2016

Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema: meta-analysis of randomized controlled trials

Liu QY, He MM, Shi H, Wang QY, Du YR, Liu JL, Ren CD, Xu D, Yu J

Drug Design, Development and Therapy 2015, 9:2527-2535

Published Date: 5 May 2015